dm+d
82573000
Articles
Treating rectal and anal disorders during breastfeeding
19 March 2024
Otigo (phenazone with lidocaine) ear drops for otitis media
1 February 2024
Lidocaine 10mg/ml spray for IUC insertion or removal
19 January 2023Template protocol for the administration of lidocaine 10mg/ml spray to facilitate intrauterine contraception (IUC) insertion or removal
Lidocaine plus prilocaine cream for IUC insertion or removal
19 January 2023Template protocol to administer topical anaesthetic cream (e.g. EMLA Cream 5%, Nulbia 5% cream) for intrauterine contraception (IUC) insertion or removal
Lidocaine: informing intrathecal risk assessment
11 August 2022Lidocaine products vary in their licensed status and other characteristics which affects their suitability for intrathecal administration
Lactation Safety Information
Intravenous as anti-arrhythmic
Intravenous
as anti-arrhythmic
-
Small amounts in breast milk
Moderate published evidence of use in breastfeeding
Minimal absorption from the infant’s GI tract
Used in full-term neonates from birth
30 July 2020
For local anaesthesia
For local anaesthesia
Limited published evidence of safety
This entry applies to all uses (infiltration, regional and surface anaesthesia and nerve blocks) and formulations (injection/topical) of lidocaine for local anaesthesia, including injections with adrenaline
Small amounts in breast milk and minimal absorption from the infant’s GI tract
30 July 2020
For ophthalmic use
For ophthalmic use
Only available in combination with fluorescein for which there are no additional risks
30 July 2020
Ointment/spray for orophayngeal use
Ointment/spray for orophayngeal use
30 July 2020
Rectal
Rectal
-
Topical/rectal use for short periods in combination with a corticosteroid considered to present minimal risk to breastfed infant
30 July 2020